Stockreport

Ankyra Appoints Sailaja Battula, PhD as Chief Scientific Officer (CSO) [Yahoo! Finance]

Immuneering Corporation - Class A  (IMRX) 
PDF technology for cancer and other diseases, today announced Sailaja Battula, PhD has been appointed as the new chief scientific officer (CSO) of Ankyra Therapeutics. Dr. B [Read more]